Technology | December 19, 2014

Volpara Solutions Launches VolparaDensity 3.0 for 2-D and 3-D Breast Density Assessment

Software suitable for use with digital mammography and digital breast tomosynthesis

Volpara, VolparaDensity, version 3.0, RSNA 2014

Image courtesy of Volpara Solutions

December 19, 2014 – Volpara Solutions announced the launch of the VolparaDensity version 3.0 breast density assessment tool at the 100th annual meeting of the Radiological Society of North America (RSNA), Nov. 30-Dec. 5 in Chicago. Available clinically for use with digital breast tomosynthesis datasets from multiple manufacturers, the system is already in use at Peninsula Diagnostic Imaging in San Mateo, Calif., and Santa Barbara Women’s Imaging in Santa Barbara, Calif. 

VolparaDensity for use with Hologic tomosynthesis systems will be available immediately and the new version for use with GE and Siemens tomosynthesis units will be available in early 2015.

A digital breast tomosynthesis exam, sometimes called a 3-D mammogram, is performed similarly to a traditional mammogram where the technologist compresses the breast and acquires images from different angles. Tomosynthesis is a multi-view mammography technique where each of the individual tomosynthesis projections acquired is a low dose, 2-D projection mammogram.

“We screen patients with dense breasts with 3-D tomosynthesis while women with fatty breasts continue to get conventional 2-D digital mammography because of the lower dose. We are excited to have the option of providing objective, volumetric breast density for all of our patients as the ability to provide consistent and accurate breast density values is critical to proper patient management. Breast density assessment should be the same no matter if the image was acquired using 2-D or 3-D.  It is, after all, the same breast, so it is very reassuring that VolparaDensity has been highly correlated between mammography and tomosynthesis,” said Susan Marks, M.D., director of breast imaging at Peninsula Diagnostic Imaging.

The VolparaDensity software, which has been in clinical use since 2010, was developed to be suitable for use with both digital mammography and digital breast tomosynthesis data from any manufacturer. It uses the same algorithm to process both the acquired tomosynthesis projections and the raw data of a conventional 2-D mammogram,  and also reduces the challenges of visually determining breast density based on a review of tomosynthesis slices and synthetic 2-D images (C-View from Hologic, V-Preview from GE) and enables consistent density assessments based on each patient’s actual breast tissue composition.

“Informing women about their breast density is critical to their ability to make informed decisions about their breast health. By providing reproducible and consistent volumetric density for 3-D tomosynthesis, VolparaDensity helps improve screening for women with dense breasts by enabling radiologists to more systematically determine which patients would benefit from supplemental imaging such as automated breast ultrasound,” said Judy Dean, M.D., senior radiologist, Santa Barbara Women’s Imaging.

VolparaDensity is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening. Highly correlated to breast magnteic resonance (MR) assessments, VolparaDensity automatically generates an objective measurement of volumetric breast density correlated to the American College of Radiology (ACR) breast density categories.

For more information: www.volparasolutons.com

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init